Otava, Ltd - synthetic organic compounds for research and drug discovery
Otava, Ltd - synthetic organic compounds for research and drug discovery
OTAVA G9a Targeted Library

OTAVA G9a Targeted Library

The OTAVA G9a Targeted Library comprises 561 carefully curated small molecules aimed at modulating the activity of histone methyltransferase G9a (EHMT2)—a master regulator of transcriptional repression through histone H3 lysine 9 (H3K9) methylation. This collection provides a powerful resource for researchers exploring epigenetics-driven mechanisms in cancer, neurodegeneration, inflammation, and stem cell reprogramming.

Read more...
 
Navigate OTAVA's CHEMRIYA™ Chemical Space with AI-Powered Similarity Search

We’re excited to introduce a powerful enhancement to your compound discovery workflow. A curated subset of OTAVA’s CHEMRIYA™ Virtual Chemical Space — comprising 1.4 billion synthetically feasible small molecules (just 2.5% of our total 55+ billion compound collection) — is now fully searchable through the AI-powered CHEESE Search platform.

This seamless integration enables researchers to explore the richness and diversity of CHEMRIYA™ using three orthogonal and precision-guided similarity search modes — each tailored to different stages of the drug discovery pipeline.

Read more...
 
Inhibitors
inhib.jpgOTAVAchemicals offers a number of INHIBITORS and other biologically active compounds modulating activity of distinct macromolecular targets

 
AI-Optimized GPCR Agonist Library

GPCR_agonists Targeted Library

The OTAVA GPCR Agonist Library is a computationally refined collection built to explore GPCR-privileged chemical space with high scaffold diversity and strong agonist-like physicochemical profiles.

Read more...
 
Targeted AHR Modulator Library

OTAVA MolGluesLike Compounds Library

The Targeted AHR Modulator Library is a curated chemical screening set designed to accelerate the discovery of novel small-molecule modulators of the aryl hydrocarbon receptor (AHR) — a ligand-dependent transcription factor with key roles in immunity, cancer, inflammation, and xenobiotic metabolism.

This unique compound library supports early-stage discovery, target validation, and therapeutic innovation by providing access to structurally diverse and computationally prioritized molecules tailored for AHR-centric research and drug development programs.

Read more...
 
«StartPrev12345678910NextEnd»

Page 4 of 17
SSL